Regulatory News
Sunday, May 22, 2016
UPDATE 2-Struggling Novartis heart drug boosted by new medical guidelines
* Amgen's Corlanor also added to guideline list
(Adds comment from Novartis chief medical officer)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment